O'Shares Investment Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-52,681
Closed -$2.98M 74
2022
Q1
$2.98M Buy
52,681
+2,828
+6% +$148K 0.24% 119
2021
Q4
$2.59M Buy
49,853
+1,543
+3% +$79.6K 0.18% 152
2021
Q3
$2.88M Buy
48,310
+3,208
+7% +$202K 0.21% 138
2021
Q2
$2.8M Buy
45,102
+1,503
+3% +$100K 0.2% 138
2021
Q1
$2.84M Buy
43,599
+1,066
+3% +$69.5K 0.21% 126
2020
Q4
$2.8M Buy
42,533
+3,059
+8% +$180K 0.21% 108
2020
Q3
$2.04M Buy
39,474
+18,590
+89% +$954K 0.21% 112
2020
Q2
$1.03M Sell
20,884
-19,991
-49% -$1.08M 0.13% 163
2020
Q1
$2.08M Sell
40,875
-3,151
-7% -$182K 0.37% 59
2019
Q4
$2.43M Buy
44,026
+639
+1% +$34.7K 0.33% 63
2019
Q3
$2.18M Buy
+43,387
New +$2.18M 0.33% 66

Other funds holding EHC

O'Shares Investment Advisers's EHC Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Encompass Health (EHC) in Q2 2022, closing a stake of 52,681 shares — an estimated $2.98M sold.

O'Shares Investment Advisers first reported a position in EHC in Q3 2019 and held it in 11 quarters. The position peaked at $2.98M in Q1 2022. 395 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

  • O'Shares Investment Advisers reported no remaining Encompass Health position as of Q2 2022 after selling out during the quarter.
  • O'Shares Investment Advisers sold 52,681 Encompass Health shares in Q2 2022, an estimated $2.98M.
  • O'Shares Investment Advisers first reported a position in Encompass Health in Q3 2019 and held it in 11 quarters.
  • O'Shares Investment Advisers's Encompass Health position peaked at $2.98M in Q1 2022.
  • 395 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.